The Role of Osteocytes in Targeted Bone Remodeling: A Mathematical Model

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Graham, Jason M ^a   Ayati, Bruce P ^b,c   Holstein, Sarah A ^c   Martin, James A ^c  

^a UNIVERSITY OF SCRANTON   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS AFFECTING METABOLISM; ANTISCLEROSTIN AGENT; ANTISCLEROSTIN ANTIBODY; BETA CATENIN; BISPHOSPHONIC ACID DERIVATIVE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SCLEROSTIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; BONE MASS; BONE REMODELING; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CELLULAR SECRETION; DRUG ACTIVITY; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MICROENVIRONMENT; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOCYTE; OSTEOLYSIS; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN SECRETION; QUALITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SIMULATION; STROMA CELL;

BONE AND BONES; BONE MORPHOGENETIC PROTEINS; BONE REMODELING; CELL DIFFERENTIATION; MODELS, THEORETICAL; OSTEOBLASTS; OSTEOCLASTS; OSTEOCYTES; OSTEOGENESIS; RANK LIGAND;

EID: 84878068274     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063884     Document Type: Article

References (59)

1. Ryser M, Komarova S, Nigam N, (2010) The cellular dynamics of bone remodeling: a mathematical model. SIAM J Appl Math 70: 1899-1921.
2. Hofbauer L, Kuehne C, Viereck V, (2004) The opg/rankl/rank system in metabolic bone diseases. J Musculoskelet Neuronal Interact 4: 268-275.
3. Hofbauer L, Schoppet M, (2004) Clinical implications of the osteoprotegerin/rankl/rank system for bone and vascular diseases. JAMA 292: 490-495.
4. Burr D, (2002) Targeted and nontargeted remodeling. Bone 30: 2-4.
5. Parfitt A, (2002) Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. Bone 30: 5-7.
6. Bonewald L, (2011) The amazing osteocyte. J Bone Miner Res 26: 229-238.
7. Neve A, Corrado A, Cantatore F, (2012) Osteocytes: central conductors of bone biology in normal and pathological conditions. Acta Physiol 204: 317-330.
8. Kular J, Tickner J, Chim S, Xu J (2012) An overview of the regulation of bone remodelling at the cellular level. Clin Biochem In Press.
9. Heino T, Kurata K, Higaki H, Väänänen H, (2009) Evidence for the role of osteocytes in the initiation of targeted remodeling. Technol Health Care 17: 49-56.
10. Geris L, Gerisch A, Maes C, Carmeliet G, Weiner R, et al. (2006) Mathematical modeling of fracture healing in mice: comparison between experimental data and numerical simulation results. Med Biol Eng Comput 44: 280-289.
11. Geris L, Gerisch A, Schugart R, (2010) Mathematical modeling in wound healing, bone regeneration and tissue engineering. Acta Biotheor 58: 1-13.
12. Geris L, Gerisch A, Sloten JV, Weiner R, Oosterwyck HV, (2008) Angiogenesis in bone fracture healing: a bioregulatory model. J Theor Bio 25: 137-158.
13. Geris L, Reed AA, Vander Sloten J, Simpson AH, Van Oosterwyck, et al. (2010) Occurrence and treatment of bone atrophic non-unions investigated by an integrative approach. PLoS Comput Bio 6: 189-193.
14. Geris L, Vander Sloten J, Van Oosterwyck H, (2010) Connecting biology and mechanics in fracture healing: an integrated mathematical modeling framework for the study of nonunions. Biomech Model Mechanobiol 9: 1-12.
15. Ayati B, Edwards C, Webb G, Wikswo J (2010) A mathematical model of bone remodeling dynamics for normal bone cell populations and myeloma bone disease. Biology Direct 5.
16. Buenzli P, Jeon J, Pivonka P, Smith D, Cummings P, (2012) Investigation of bone resorption within a cortical basic multicellular unit using a lattice-based computational model. Bone 50: 378-389.
17. Buenzli P, Pivonka P, Gardiner B, Smith D, (2012) Modelling the anabolic response of bone using a cell population model. J Theor Biol 307C: 42-52.
18. Buenzli P, Pivonka P, Smith D, (2011) Spatio-temporal structure of cell distribution in cortical bone multicellular units: a mathematical model. Bone 48: 918-926.
19. Defranoux N, Stokes C, Young D, Kahn A, (2005) In silico modeling and simulation of bone biology: a proposal. J Bone Miner Res 20: 1079-1084.
20. Graham J, Ayati B, Ramakrishnan P, Martin J, (2012) Towards a new spatial representation of bone remodeling. Math Biosci Eng 9: 281-295.
21. Komarova S, (2005) Mathematical model of paracrine interactions between osteoclasts and osteoblasts predicts anabolic action of parathyroid hormone on bone. J Endocrinol 146: 3589-3595.
22. Komarova S, Smith R, Dixon S, Sims S, Wahl L, (2003) Mathematical model predicts a critical role for osteoclast autocrine regulation in the control of bone remodeling. Bone 33: 225-234.
23. Lemaire V, Tobin F, Greller L, Cho C, Suva L, (2004) Modeling the interactions between osteoblast and osteoclast activities in bone remodeling. J Theor Biol 229: 293-309.
24. Liotier P, Rossi J, Wendling-Mansuy S, Chabrand P (2012) Trabecular bone remodelling under pathological conditions based on biochemical and mechanical processes involved in bmu activity. Comput Methods Biomech Biomed Engin In Press.
25. Martin M, Buckland-Wright J, (2004) Sensitivity analysis of a novel mathematical model identifies factors determining bone resorption rates. Bone 35: 918-928.
26. Martin M, Buckland-Wright J, (2005) A novel mathematical model identifies potential factors regulating bone apposition. Calcif Tissue Int 77: 250-260.
27. Pivonka P, Komarova S, (2010) Mathematical modeling in bone biology: From intracellular signaling to tissue mechanics. Bone 47: 181-189.
28. Pivonka P, Zimak J, Smith D, Gardiner B, Dunstan C, et al. (2008) Model structure and control of bone remodeling: A theoretical study. Bone 43: 249-263.
29. Pivonka P, Zimak J, Smith D, Gardiner B, Dunstan C, et al. (2010) Theoretical investigation of the role of the rank-rankl-opg system in bone remodeling. J Theor Biol 262: 306-316.
30. Ryser M, Nigam N, Komarova S, (2009) Mathematical modeling of spatio-temporal dyanmics of a single bone multicellular unit. J Bone Miner Res 24: 860-870.
31. Zumsande M, Stiefs D, Siegmund S, Gross T, (2011) General analysis of mathematical models for bone remodeling. Bone 48: 910-917.
32. Savageau M, (1969) Biochemical systems analysis. i. some mathematical properties of the rate law for the component enzymatic reactions. J Theor Biol 25: 365-369.
33. Savageau M, (1969) Biochemical systems analysis. ii. the steady-state solutions for an n-pool system using a power-law approximation. J Theor Biol 25: 370-379.
34. Savageau M, (1970) Biochemical systems analysis. iii. dynamic solutions using a power-law approximation. J Theor Biol 26: 215-226.
35. Savageau M (1976) Biochemical systems analysis. Reading, MA: Addison-Wesley.
36. Voit E (2000) Computational analysis of biochemical systems. Cambridge, UK: Cambridge University Press.
37. Lio P, Paoletti N, Atwell M, Merelli E, Viceconti M (2012) Modelling osteomyelitis. BCM Bioinformatics 13 Suppl 14.
38. Bilezikian J, Raisz L, Rodan G (2002) Principles of bone biology. Boston: Academic Press, second edition.
39. Bell N, (2003) Rankl and the regulation of skeletal remodeling. J Clin Invest 111: 1120-1122.
40. Hofbauer L, Heufelder A, (2001) Role of receptor activator of nuclear factor-b ligand and osteoprotegerin in bone cell biology. J Mol Med 79: 243-253.
41. Martin T, (2004) Paracrine regulation of osteoclast formation and activity: milestones in discovery. J Musculoskelet Neuronal Interact 4: 243-253.
42. Simonet W, Lacey D, Dunstan C, Kelley M, Chang M, et al. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89: 309-319.
43. Cohen M, (1997) Transforming growth factor beta's and fibroblast growth factors and their receptors: role in sutural biology and craniosynostosis. J Bone Miner Res 12: 322-331.
44. Janssens K, ten Dijke P, Janssens S, Hul WV, (2005) Transforming growth factor-beta1 to the bone. Endocr Rev 26: 743-744.
45. Boyle W, Simonset W, Lacey D, (2003) Osteoclast differentiation and activation. Nature 423: 337.
46. Gori F, LC Hofbauer, Dunstan C, Spelsberg T, et al. (2000) The expression of osteoprotegerin and rank ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology 141: 4768-76.
47. Cardoso L, Herman B, Verborgt O, Laudier D, Majeska R, et al. (2009) Osteocyte apoptosis controls activation of intracortical resoprtion in response to bone fatique. J Bone Min Res 24: 597-605.
48. Xiong J, Onal M, Jilka R, Weinstein R, Manolagas S, et al. (2002) Matrix-embedded cells control osteoclast formation. Nature Med 17: 1235-1242.
49. Shampine L, Reichelt M, (1997) The MATLAB ODE suite. SIAM J Sci Comput 18: 1-22.
50. Shampine LF, Gladwell I, Thompson S (2003) Solving ODEs with MATLAB. Cambridge: Cambridge University Press, viii+263 pp. doi:10.1017/CBO9780511615542. Available: http://dx.doi.org/10.1017/CBO9780511615542.
51. Shampine L (1994) Numerical solution of ordinary differential equations. New York: Chapman & Hall, x+484 pp.
52. Giuliani N, Ferretti M, Bolzoni M, Storti P, Lazzaretti M, et al. (2012) Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation. Leukemia 26: 1391-1401.
53. Lewiecki E, (2011) Sclerostin: a novel target for intervention in the treatment of osteoporosis. Discov Med 12: 263-273.
54. Lim V, Clarke B, (2012) New therapeutic targets for osteoporosis: Beyond denosumab. Maturitas 73: 269-272.
55. Ayati B, Graham J, Holstein S (2012) Using a level set to model multiple myeloma induced bone loss. Proceedings of the 6th European Congress on Computational Methods in Applied Sciences and Engineering.
56. Manolagas S, Parfitt A (2012) For whom the bell tolls: Distress signals from long-lived osteocytes and the pathogenesis of metabolic bone diseases. Bone.
57. Ardawi M, Rouzi A, Al-Sibiani S, Al-Senani N, Qari M, et al. (2012) High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: The center of excellence for osteoporosis research study. J Bone Miner Res 27: 2592-2602.
58. Yavropoulou M, va Lierop A, Handy N, (2012) Serum sclerostin levels in paget's disease and prostate cancer with bone metastases with a wide range of bone turnover. Bone 51: 153-157.
59. Brunetti G, Oranger A, Mori G, Specchia G, Rinaldi E, et al. (2011) Sclerostin is overexpressed by plasma cells from multiple myeloma patients. Ann NY Acad Sci 1237: 19-23.